NASDAQ · Drug Manufacturers - Specialty & Generic

SHPH (SHPH) Stock

$3.65 +8.31% NASDAQ: SHPH Healthcare

Valuation

MetricValue
Price$3.65
Market Cap$2.14M
P/E Ratio-0.31
P/B Ratio0.59
P/S Ratio0.00
EPS (TTM)$-7.16
52-Week High$55.90
52-Week Low$2.79
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-7.91%
ROA-1.15%
ROCE-528.59%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.10
Current Ratio0.13

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-2.0M$-2.0M$-6.0M$-8.0M$-12.0M
Net Profit$-1.0M$-5.0M$-7.0M$-9.0M$-12.0M
EPS$-0.09$-0.30$-0.41$-885.73$-7.16
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.0M$9.0M$6.0M$3.0M$10.0M
Total Liabilities$2.0M$1.0M$2.0M$2.0M$8.0M
Cash$1.0M$8.0M$3.0M$2.0M$0
Borrowings$1.0M$1.0M$1.0M$1.0M$0

Latest News

Shuttle to Acquire United Dogecoin in Push to Build Public DOGE Mining Platform CryptoProwl · May 1, 2026 RETRANSMISSION: Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows TMX Newsfile · Mar 27, 2026 Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows TMX Newsfile · Mar 26, 2026 E.F. Hutton & Co. Serves as Exclusive Placement Agent on Shuttle Pharmaceuticals’ $3.5 Million Public Offering GlobeNewswire · Mar 12, 2026 Shuttle Pharmaceuticals Announces $3.5 Million Public Offering TMX Newsfile · Mar 6, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$-3.0M$-6.0M$-7.0M$-9.0M
Investing Cash Flow$0$0$-3.0M$3.0M$-3.0M
Financing Cash Flow$0$0$-1.0M$0$0
Net Cash Flow$0$8.0M$-6.0M$-1.0M$-2.0M
Free Cash Flow$0$-3.0M$-6.0M$-7.0M$-9.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-0.31
FCF Yield-1331.57%
Quick Ratio0.06
Interest Coverage—
Return 1Y-92.23%
Return 3Y-99.82%
Return 5Y—

Ownership

Insiders Held0.94%
Institutions Held2.99%
Institutions Float Held3.02%
Institutional HolderSharesReport Date
Ikarian Capital, LLC68,9932025-12-31
Boothbay Fund Management, LLC20,3602025-12-31
Geode Capital Management, LLC14,4442025-12-31
UBS Group AG5,6702026-03-31
Tower Research Capital LLC (TRC)8122025-12-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AKAN $5.31 -16.90% -0.06 $171863 0.00%
BBLG $1.02 -4.21% -1.10 $1.84M 0.00%
BIVI $1.52 +6.29% -0.11 $11.46M 0.00%
HSCS $2.18 +4.81% -0.70 $4.71M 0.00%
IMCC $0.12 +0.26% -1062.50 $357295 0.00%

About SHPH

SHPH is led by CEO Christopher Robert Cooper, employs 9 people, headquartered in US, publicly traded since 2022.

SHPH stock trades at $3.65 with a market capitalization of $2.14M. The stock is valued at a price-to-earnings (P/E) ratio of -0.31, price-to-book of 0.59, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $2.79 and $55.90, and currently trades 93.5% below its 52-week high.

On profitability, SHPH generates a return on equity (ROE) of -7.91%, return on capital employed of -528.59%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides